Abstract:Silymarin, a phyto-constituent derived from the plant Silybum marianum, has been widely acknowledged for its hepatoprotective activities. Nevertheless, its clinical utility is adversely hampered by its poor water-solubility and its limited oral bioavailability. The aim of this study was to investigate the efficacy of phospholipid-based phytosomes for enhancing the oral bioavailability of silymarin. The phytosomes were prepared using the solvent evaporation technique and were optimized using a full factorial design. The optimized silymarin phytosomal formulation was then characterized for particle size, surface morphology, aqueous solubility, and in vitro drug release. Furthermore, in vivo antioxidant activity, hepatoprotective activity and oral bioavailability of the optimized formula were investigated in a rat model. The prepared silymarin phytosomes were discrete particles with a porous, nearly smooth surface and were 218.4 ± 2.54 nm in diameter. In addition, the optimized silymarin phytosomal formulation showed a significant improvement in aqueous solubility (~360 μg/mL) compared to pure silymarin and manifested a higher rate and extent of silymarin release from the optimized formula in dissolution studies. The in vivo assessment studies revealed that the optimized silymarin phytosomal formulation efficiently exerted a hepatoprotective effect in a CCl4-induced hepatotoxicity rat model via restoring the normal levels of antioxidant enzymes and ameliorating cellular abnormalities caused by CCl4-intoxication. Most notably, as compared to pure silymarin, the optimized silymarin phytosomal formulation significantly improved silymarin oral bioavailability, as indicated by a 6-fold increase in the systemic bioavailability. Collectively, phytosomes might represent a plausible phospholipid-based nanocarrier for improving the oral bioavailability of phyto-constituents with poor aqueous solubility.

Preparation and quality evaluation of silybin proliposomes

Binary lipids-based nanostructured lipid carriers for improved oral bioavailability of silymarin.

Preparation and Characterization of Silybin-Loaded Nanostructured Lipid Carriers

Optimization of solid lipid nanoparticles of silymarin by using Box-Behnken experimental design

Silymarin Glyceryl Monooleate/Poloxamer 407 Liquid Crystalline Matrices: Physical Characterization and Enhanced Oral Bioavailability

Clinical trials in the elderly--a concept comes of age.

Auditory processing in children's speech perception: results of selective adaptation and discrimination tasks.

Supersaturated polymeric micelles for oral silybin delivery: the role of the Soluplus-PVPVA complex

Delivery of Silybin Using a Zein-Pullulan Nanocomplex: Fabrication, Characterization, in Vitro Release Properties and Antioxidant Capacity

Preparation of silymarin suspension and evaluation of its stability and release

Self-assembly and characterization of Pluronic P105 micelles for liver-targeted delivery of silybin.

Nanostructured Lipid Carriers for Parenteral Delivery of Silybin: Biodistribution and Pharmacokinetic Studies.

The Efficiency and Mechanism of N-octyl-O, N-carboxymethyl Chitosan-Based Micelles to Enhance the Oral Absorption of Silybin

Design of novel proliposome formulation for antioxidant peptide, glutathione with enhanced oral bioavailability and stability

Preparation and Preliminary Safety Evaluation of Carboplatin Proliposomes

Preparation Technology of Sinomenine Hydrochloride Liposomes

Vascular and neural changes in the rat optic nerve following induction of diabetes with streptozotocin.

Phytosomes as a Plausible Nano-Delivery System for Enhanced Oral Bioavailability and Improved Hepatoprotective Activity of Silymarin

Preparation and evaluation of proliposomes formulation for enhancing the oral bioavailability of ginsenosides

<i>In vitro</i>and<i>in vivo</i>evaluation of silybin nanosuspensions for oral and intravenous delivery

The Pharmacokinetics and Liver-Targeting Evaluation of Silybin Liposomes Mediated by the NTCP/OCTN2 Dual Receptors